Akcea’s top 3 C-suite ex­ecs are chopped out as Io­n­is sends in an in­ter­im quar­ter­back from their bench

4 years ago
R&D

New Flag­ship biotech wants to un­leash your genome

4 years ago
Startups

Here comes the oral GLP-1 drug for di­a­betes — and No­vo Nordisk wants to price Ry­bel­sus 'at a sim­i­lar lev­el as Ozem­pic'

4 years ago
R&D
Pharma

In­trex­on unit push­es back against claims its GM mos­qui­toes are mak­ing dis­ease-friend­ly mu­tants

4 years ago
R&D
FDA+

As Nas­daq en­rolls the fi­nal batch of 2019 IPOs, how have the num­bers com­pared to past years?

4 years ago
Financing

Eye­ing big ther­a­peu­tic push, Gink­go bags $290M to build a cell pro­gram­ming em­pire

4 years ago
Financing

'Dis­con­nect the bas­tard­s' — one biotech's plan to break can­cer cell­s' uni­fied de­fens­es

4 years ago
R&D
Cell/Gene Tx

Sen­a­tors to FTC: Don't let the big Cel­gene and Al­ler­gan buy­outs hurt R&D and con­sumers

4 years ago
People
R&D

A fa­vorite in Alex­ion’s C-suite is leav­ing, and some mighty sur­prised an­a­lysts aren’t the least bit hap­py about it

4 years ago
People

Pre­clin­i­cal can­cer biotech IGM Bio­sciences sets stage for up­sized $175M IPO

4 years ago
Financing
Startups

San Diego cou­ple charged with steal­ing trade se­crets, open­ing Chi­nese biotech as DOJ crack­down con­tin­ues

4 years ago
R&D
China

Scott Got­tlieb is once again join­ing a team that en­joyed good times at the FDA un­der his high-en­er­gy stint at the helm

4 years ago
People

Bio­gen pulls the plug on prized IPF drug from $562M+ Stromedix buy­out

4 years ago
R&D

Scott Got­tlieb has a new board po­si­tion to add to the re­sume — and this one is fo­cused on a fa­vorite sub­ject

4 years ago
People
Pharma

Deb­o­rah Dun­sire is pay­ing $2B for a chance to leap di­rect­ly in­to a block­buster show­down with a few of the world's biggest phar­ma gi­ants

4 years ago
Deals

It's not per­fect, but it's a good start: FDA pan­elists large­ly en­dorse Aim­mune's peanut al­ler­gy ther­a­py

4 years ago
R&D
FDA+

It’s fi­nal­ly over: Bio­gen, Ei­sai scrap big Alzheimer’s PhI­I­Is af­ter a pre­dictable BACE cat­a­stro­phe rais­es safe­ty fears

4 years ago
R&D

Star founders, in­ves­ti­ga­tors hud­dle around new Boston ac­cel­er­a­tor spot­light­ing young en­tre­pre­neurs

4 years ago
Startups

Chalk up a big win for Bain as Spring­Works IPO tops out at $162M

4 years ago
Financing

FDA slaps a hold on one of Am­gen’s ear­ly-stage can­cer drugs, rais­ing car­diac tox con­cerns for a top prospect in the pipeline

4 years ago
R&D

Penn team adapts CAR-T tech, reengi­neer­ing mouse cells to treat car­diac fi­bro­sis

4 years ago
R&D

The mR­NA uni­corn Mod­er­na has more ear­ly-stage hu­man da­ta it wants to show off — reach­ing new peaks in prov­ing the po­ten­tial

4 years ago
R&D

Mer­ck KGaA touts FDA 'break­through' sta­tus, block­buster po­ten­tial in bid to woo in­vestors

4 years ago
R&D

Af­ter plen­ty of due dili­gence, GSK buys one biotech pup in the ‘$500M’ Aval­on lit­ter for its pipeline

4 years ago
Deals
First page Previous page 157158159160161162163 Next page Last page